The company expects fiscal 2026 revenue to be between $18.7 billion and $19 billion, compared with $11.70 billion in fiscal 2025.
Oscar Health (OSCR) shares rebounded from early losses to rise more than 5% in pre-market trading on Tuesday after the company projected fiscal 2026 revenue well above the FY2025 level reported alongside its fourth-quarter results.
Q4 total revenue came in at $2.81 billion, significantly below the Street estimates of $3.12 billion, according to Fiscal.ai data. The company reported a loss of $1.24 per share, wider than the estimates of a loss of $0.92 per share.
The company expects fiscal 2026 revenue to be between $18.7 billion and $19 billion, compared with $11.70 billion in fiscal 2025. Oscar Health also expects earnings from operations between $250 and $450 million in FY2026.
Read updates to this developing story on Stocktwits.<
For updates and corrections, email newsroom[at]stocktwits[dot]com<